No results were found for the filter!
G-type iODN (inhibitory ODN) Endotoxin-free (sterile) Item number: IAX-200-052-M001
Potent sequence of an inhibitory ODN of the poly-G class I targeting TLR9, but without effect on TLR7 and TLR8 signaling, for in vivo use in rodents (50-150 µg per injection). Negative control: Neutral-ODN (Cat. No.: IAX-200-202).
| Keywords: | Inhibitory ODN (iODN): Class I |
| Application: | TLR9 competitor |
| MW: | 6735 D |
From 98.00€ *
ODN 2138 (Control for ODN 1826) Endotoxin-free (sterile) Item number: IAX-200-201-C100
Negative control GpC ODN for in vivo use in rodents (50-150 µg per injection). As active compound use CpG ODN 1826 (Cat. No.: IAX-200-002). For negative control without agonistic nor antagonistic activity: Neutral-ODN (Cat. No.: IAX-200-202).
| Application: | Negative Control for ODN 1826 (IAX-200-002) |
| MW: | 6383 D |
98.00€ *
![Polyinosinic-polycytidylic acid [Poly(I:C)] Endotoxin-free (sterile)](https://www.biomol.com/media/image/c1/8e/e3/IAX-200-021-M002_200x200.png "Polyinosinic-polycytidylic acid [Poly(I:C)] Endotoxin-free (sterile)")
Polyinosinic-polycytidylic acid [Poly(I:C)]... Item number: IAX-200-021-M005
Activates TLR3, MDA5/Helicard and RIG-I. Optimal working concentration depends upon target receptor accessibility, number, density, as well as cell type, and therefore needs to be determined for each application. Recommended concentration range: in vitro: 0.5-10 µg/ml, in vivo: 5mg/kg.
| Keywords: | Polyinosinic-polycytidylic acid, potassium salt (poly (I:C)) |
| Application: | TLR3, MDA5/Helicard, RIG-I activator |
From 112.00€ *
ODN 1668 (Type B) Endotoxin-free (sterile) Item number: IAX-200-001-M001
3 x 1 mg. Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 1720 (Cat. No.: IAX-200-200).
| Keywords: | CpG ODN TLR9 Agonist: B Type (species: rodent) |
| Application: | TLR9 activator |
| MW: | 6383 D |
From 125.00€ *
ODN M362 (Type C) Endotoxin-free (sterile) Item number: IAX-200-004-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2243 (Cat. No.: IAX-200-205).
| Keywords: | CpG ODN TLR9 Agonist: A Type (species: human and rodent) |
| Application: | TLR9 activator |
| MW: | 6644 D |
From 125.00€ *
ODN 1826 (Type B) Endotoxin-free (sterile) Item number: IAX-200-002-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 1982 (Cat. No.: IAX-200-201).
| Keywords: | CpG ODN TLR9 Agonist: B Type (species: rodent) |
| Application: | TLR9 activator |
| Reactivity: | Mouse, Rat |
| MW: | 6383 D |
From 125.00€ *
ODN 2006 (Type B) Endotoxin-free (sterile) Item number: IAX-200-006-C100
3 x 1 mg. Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.7-7.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2137 (Cat. No.: IAX-200-206).
| Keywords: | CpG ODN TLR9 Agonist: B Type (species: human and rodent) |
| Application: | TLR9 activator |
| MW: | 7720 D |
From 125.00€ *
ODN 1585 (Type A) Endotoxin-free (sterile) Item number: IAX-200-003-M001
Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2218 (Cat. No.: IAX-200-203). Unmethylated CG dinucleotides within particular sequence contexts are responsible for the...
| Keywords: | CpG ODN TLR9 Agonist: A Type (species: rodent) |
| Application: | TLR9 activator |
| MW: | 6643 D |
From 125.00€ *
ODN 2216 (Type A) Endotoxin-free (sterile) Item number: IAX-200-005-C100
Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2243 (Cat. No.: IAX-200-205).
| Keywords: | CpG ODN TLR9 Agonist: A Type (species: human and rodent) |
| Application: | TLR9 activator |
| MW: | 6644 D |
From 125.00€ *
iODN (inhibitory ODN) 2088 Endotoxin-free (sterile) Item number: IAX-200-050-3001
Potent sequence of an inhibitory ODN for in vivo use in rodents (50-150 µg per injection): prototype class I, may also affect TLR7 and TLR8 signaling. Negative control: Neutral-ODN (Cat. No.: IAX-200-202).
| Keywords: | Inhibitory ODN (iODN): Class I |
| Application: | TLR9 competitor |
| MW: | 4887 D |
From 98.00€ *
Neutral-ODN (Control for iODNs) Endotoxin-free (sterile) Item number: IAX-200-202-3001
3 x 1 mg. Negative control GpC ODN for in vivo use in rodents (50-150 µg per injection). As active compound use CpG ODN 1585 (Cat. No.: IAX-200-003). For negative control without agonistic nor antagonistic activity: Neutral-ODN (Cat. No.: IAX-200-202).
| Application: | Negative Control for ODN 1585 (IAX-200-003) |
| MW: | 4821 D |
From 98.00€ *
ODN 2395 (Type C) Endotoxin-free (sterile) Item number: IAX-200-007-C100
3 x 1 mg. Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.7-7.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: Neutral-ODN (Cat. No.: IAX-200-202).
| Keywords: | CpG ODN: C Type (species: human and rodent) |
| Application: | TLR9 activator |
| MW: | 7068 D |
From 125.00€ *
Viewed